The current valuation score of Evolus Inc is 9.30, ranking 34 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -10.09, which is -54.97% below the recent high of -4.54 and -91.49% above the recent low of -19.32.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.